MNOV - Medicinova Inc
IEX Last Trade
1.5
0.190 12.667%
Share volume: 116,033
Last Updated: Fri 30 Aug 2024 09:59:30 PM CEST
Research and Development in Biotechnology (except Nanobiotechnology):
0.21%
PREVIOUS CLOSE
CHG
CHG%
$1.31
0.19
14.50%
Summary score
13%
Profitability
0%
Dept financing
2%
Liquidity
50%
Performance
20%
Sector
Professional, Scientific, and Technical Services
Industry
Research and Development in Biotechnology (except Nanobiotechnology)
Long-term ratios 30-Jun-2016 - 30-Jun-2020
The data are presented for the financials results of the quarters of the last 4 years.
Return on equity
-5.87%
Return on assets
-5.81%
Return on sales
0%
Return on invested capital
-24.13%
Total debt ratio
8.03%
Debt ratio change over timeo
-1.56%
Current Ratio
28.17%
Quick Ratio
0%
Cash Position Ratio
27.85%
Short-term ratios 30-Jun-2019 - 30-Jun-2020
The data are presented for the financials results of the quarters of the last year.
Return on equity
-4.04%
Return on assets
-4.05%
Return on sales
0%
Return on invested capital
-23.56%
Total debt ratio
5.55%
Debt ratio change over timeo
-1.29%
Current Ratio
29.12%
Quick Ratio
0%
Cash Position Ratio
28.9%
Last quarter ratios 30-Jun-2020
The data are presented for the financials results of the last quarter.
Return on equity
-6.26%
Return on assets
-5.95%
Return on sales
0%
Return on invested capital
-37.04%
Total debt ratio
6.26%
Debt ratio change over time
-1.4%
Current Ratio
22.01%
Quick Ratio
0%
Cash Position Ratio
21.79%
Performance ratios (change over 4 years) 30-Jun-2016 - 30-Jun-2020
The data are presented for the change financials results of the quarter of the last 4 years.
Return on equity
-45.73%
Return on assets
-46.25%
Return on sales
0%
Return on invested capital
158.14%
Total debt ratio
-156.13%
Debt ratio change over time
-1.56%
Current Ratio
-318.69%
Quick Ratio
0%
Cash Position Ratio
-315.44%
Compare in sector
The following table compares the individual analyzes for the other top 3 stocks within the same industry.
| Long-term ratios | MNOV | ABBV | AMGN | REGN |
|---|---|---|---|---|
| Return on equity | -5.87% | -3.05% | 11.55% | 6.27% |
| Return on assets | -5.81% | 3.6% | 3.57% | 5.27% |
| Return on sales | 0% | 32.14% | 42.16% | 33.08% |
| Return on invested capital | -24.13% | 5.09% | 7.99% | 13.19% |
| Profitability | 0% | 46% | 82% | 83% |
| Total debt ratio | 8.03% | 101.18% | 74.11% | 29.58% |
| Debt ratio change over time | -1.56% | 6.09% | 6.03% | 1.53% |
| Dept financing | 2% | 50% | 43% | 14% |
| Current Ratio | 29.12% | 2.08% | 2.02% | 3.51% |
| Quick Ratio | 0% | 1.96% | 1.71% | 2.86% |
| Cash Position Ratio | 28.9% | 1.48% | 0.76% | 1.49% |
| Liquididy | 50% | 12% | 29% | 27% |
| Short-term ratios | MNOV | ABBV | AMGN | REGN |
|---|---|---|---|---|
| Return on equity | -4.04% | -25.62% | 17.94% | 7.14% |
| Return on assets | -4.05% | 3.26% | 3.67% | 4.71% |
| Return on sales | 0% | 31.22% | 37.5% | 33.58% |
| Return on invested capital | -23.56% | 8.14% | 7.17% | 18.16% |
| Profitability | 0% | 49% | 79% | 82% |
| Total debt ratio | 5.55% | 105.33% | 83.42% | 27.49% |
| Debt ratio change over time | -1.29% | -23.44% | 9.66% | 0.6% |
| Dept financing | 1% | 25% | 45% | 8% |
| Current Ratio | 29.12% | 2.08% | 2.02% | 3.51% |
| Quick Ratio | 0% | 1.96% | 1.71% | 2.86% |
| Cash Position Ratio | 28.9% | 1.48% | 0.76% | 1.49% |
| Liquididy | 50% | 20% | 17% | 29% |